Avidity Biosciences, Inc.

NASDAQ:RNA

46.73 (USD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -212.22-173.995-118.009-44.355-24.734-11.216
Depreciation & Amortization 2.1011.3870.6390.3730.3480.383
Deferred Income Tax -1.769000.08400
Stock Based Compensation 38.22227.13917.0564.310.4060.06
Change In Working Capital 61.1299.8165.3382.33219.1230.671
Accounts Receivables 000000
Inventory 000000
Accounts Payables 1.76918.3156.0435.7490.4510.78
Other Working Capital 59.36-8.499-0.705-3.41718.6720.671
Other Non Cash Items -6.527-0.6150.1630.1397.3470.447
Operating Cash Flow -119.064-136.268-94.813-37.1172.49-9.655
Investing Activities:
Investments In Property Plant And Equipment -4.228-2.823-3.74-1.092-0.235-0.049
Acquisitions Net 125.842187.13282.517000
Purchases Of Investments -461.002-355.837-85.357-6.69300
Sales Maturities Of Investments 335.16168.7056.58000
Other Investing Activites -125.842-187.132-82.517-6.69300
Investing Cash Flow -130.07-189.955-82.517-7.785-0.235-0.049
Financing Activities:
Debt Repayment 000-4.68316.6514.982
Common Stock Issued 60.547344.779174.677274.0540.0650.162
Common Stock Repurchased 000000
Dividends Paid 0000-0.1060
Other Financing Activities 33.3171.3921.6392.66672.6880.162
Financing Cash Flow 93.864346.171176.316272.03789.2335.144
Other Information:
Effect Of Forex Changes On Cash -0.04400000
Net Change In Cash -155.31419.948-1.014227.13591.488-4.56
Cash At End Of Period 185.082340.647320.699321.71394.5783.09